Scholar Rock
A clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.
Scholar Rock is creating a pipeline of novel product candidates with the potential to transform the lives of patients suffering from a wide range of serious diseases, including neuromuscular disorders, cancer, and fibrosis.
Latest Scholar Rock News & Features
25 October 2022
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze